Skip to main content
Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · IEX Real-Time Price · USD
1.710
-0.150 (-8.06%)
At close: May 17, 2024, 4:00 PM
1.760
+0.050 (2.92%)
After-hours: May 17, 2024, 7:51 PM EDT

Atai Life Sciences Revenue

Atai Life Sciences had revenue of $277.00K in the twelve months ending March 31, 2024, with 2.97% growth year-over-year. In the year 2023, Atai Life Sciences had annual revenue of $314.00K with 34.76% growth.

Revenue (ttm)
$277.00K
Revenue Growth
+2.97%
P/S Ratio
1,033.49
Revenue / Employee
$3,337
Employees
83
Market Cap
286.28M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023314.00K81.00K34.76%
Dec 31, 2022233.00K-20.14M-98.86%
Dec 31, 202120.38M--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 1.19B
Sharecare 419.82M
23andMe Holding Co. 247.99M
Xeris Biopharma Holdings 171.36M
SOPHiA GENETICS 64.18M
MacroGenics 43.36M
TriSalus Life Sciences 21.98M
Adaptimmune Therapeutics 18.36M
Revenue Rankings

ATAI News

More News